MicroPort CardioFlow Medtech Corporation (MP CardioFlow) reported that Dr. Brian Chang has stepped down as Non-Executive Director, effective 30 October 2026, to focus on other professional commitments. Dr. Chang confirmed there is no disagreement with the Board and no additional matters requiring shareholder attention. The Board expressed gratitude for his contributions.

Concurrently, the company restructured its Board committees:

• Dr. Chang relinquished his roles as member of the Audit Committee, Chairperson of the Strategy Committee and member of the Commercialization Committee.

• Non-Executive Director Mr. Deng Aoyi and Independent Non-Executive Director Mr. Mao Junxiang have joined the Audit Committee.

• Executive Director Mr. Chen Guoming, previously a member of the Strategy Committee, has been appointed its Chairperson.

Until a new Chairman is named, Mr. Chen Guoming will preside over Board meetings and coordinate Board operations.

As of the announcement date, MP CardioFlow’s Board consists of Executive Directors Mr. Chen Guoming, Mr. Zhang Ruinian and Mr. Philippe Wanstok; Non-Executive Director Mr. Deng Aoyi; and Independent Non-Executive Directors Mr. Jonathan H. Chou, Ms. Sun Zhixiang, Dr. Hu Bingshan and Mr. Mao Junxiang.